Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors

Antithymocyte globulin (ATG) is widely used to reduce acute graft-versus-host disease (aGVHD) and chronic GVHD (cGVHD). To clarify the different impacts of ATG for conditioning across different donor types, we retrospectively analyzed patients with acute leukemia (n = 6617) who underwent hematopoiet...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Blood Adv
Autori principali: Wakamatsu, Manabu, Terakura, Seitaro, Ohashi, Kazuteru, Fukuda, Takahiro, Ozawa, Yukiyasu, Kanamori, Heiwa, Sawa, Masashi, Uchida, Naoyuki, Ota, Shuichi, Matsushita, Akiko, Kanda, Yoshinobu, Nakamae, Hirohisa, Ichinohe, Tatsuo, Kato, Koji, Murata, Makoto, Atsuta, Yoshiko, Teshima, Takanori
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2019
Soggetti:
Transplantation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6341193/
https://ncbi.nlm.nih.gov/pubmed/30626574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018025643
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi